Antiproliferative Activities of Citrus Flavonoids
J. Agric. Food Chem., Vol. 50, No. 21, 2002 5843
(4) Tanaka, Y.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto,
M.; Satoh, K.; Hara, A.; Sumida, T.; Fukutani, K.; Tanaka, T.;
Ogawa, H. Modulation of N-methyl-N-nitrosamine-induced rat
oesophageal tumorigenesis by dietary feeding of diosmin and
hesperidin, both alone and in combination. Carcinogenesis 1997,
18, 761-769.
(23) Hansen, M. B.; Nielsen, S. E.; Berg, K. Re-examination and
further development of a precise and rapid dye method for
measuring cell growth/cell kill. J. Immunol. Methods 1989, 119,
203-210.
(24) Rusznya´k, S.; Szent-Gyo¨rgyi, A. Vitamin P. Flavonols as
vitamins. Nature 1936, 138, 27.
(5) Tanaka, Y.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto,
M.; Satoh, K.; Hara, A.; Sumida, T.; Fukutani, K.; Tanaka, T.;
Ogawa, H. Chemoprevention of azoxymethane-induced rat colon
carcinogenesis by the naturally occurring flavonoids, diosmin
and hesperidin. Carcinogenesis 1997, 18, 957-965.
(6) Yang, M.; Tanaka, T.; Hirose, Y.; Deguchi, T.; Mori, H.;
Kawada, Y. Chemopreventive effects of diosmin and hesperidin
on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary-
bladder carcinogenesis in male ICR mice. Int. J. Cancer 1997,
73, 719.
(7) Kandaswami, C.; Perkins, E.; Soloniuk, D. S.; Drzewiecki, G.;
Middleton, E., Jr. Antiproliferative effects of citrus flavonoids
on a human squamous cell carcinoma in vitro. Cancer Lett. 1991,
56, 147-152.
(25) Bruckner, V.; Szent-Gyo¨rgyi, A. Chemical nature of citrin.
Nature 1936, 138, 1057.
(26) Martin, G. J. Biochemistry of the bioflavonoids. Ann. N. Y. Acad.
Sci. 1955, 61, 646-651.
(27) Vinson, J. A.; Sheu-Ju, H.; Sunah J.; Stanski, A. M. A citrus
extract plus ascorbic acid decreases lipids, lipid peroxides,
lipoprotein oxidative susceptibility, and atherosclerosis in hy-
percholesterolemic hamsters. J. Agric. Food Chem. 1998, 46,
1453-1459.
(28) Manthey, J. A.; Grohmann, K.; Montanari, A.; Ash, K.; Manthey,
C. L. Polymethoxylated flavones derived from citrus suppress
tumor necrosis factor-R expression by human monocytes. J. Nat.
Prod. 1999, 62, 441-444.
(8) Sugiyama, S.; Umehara, K.; Kuroyanagi, M.; Ueno, A.; Taki,
T. Studies on the differentiation inducers of myeloid leukemic
cells from Citrus species. Chem. Pharm. Bull. 1993, 41, 714-
719.
(9) Hirano, T.; Abe, K.; Gotoh, M.; Oka, K. Citrus flavone tangeretin
inhibits leukemic HL-60 cell growth partially through induction
of apoptosis with less cytotoxicity on normal lymphocytes. Br.
J. Cancer 1995, 72, 1380-1388.
(10) Mak, N. K.; Wong-Leung, Y. L.; Chan, S. C.; Wen, J.; Leung,
K. N.; Fung, M. C. Isolation of anti-leukemia compounds from
Citrus reticulata. Life Sci. 1996, 58, 1269-1276.
(11) Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Effect
of citrus flavonoids on HL-60 cell differentiation. Anticancer
Res. 1999, 19, 1261-1270.
(12) Kawaii, S.; Yomono, Y.; Katase, E.; Ogawa, K.; Yano, M.
Antiproliferative activity of flavonoids on several cancer cell
lines. Biosci., Biotechnol., Biochem. 1999, 63, 896-899.
(13) Iwase, Y.; Takemura, Y.; Ju-ichi, M.; Yano, M.; Ito, C.;
Furukawa, H.; Mukainaka, T.; Kuchide, M.; Tokuda, H.; Nishino,
H. Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-hep-
tamethoxyflavone from the peel of citrus plants. Cancer Lett.
2001, 163, 7-9.
(14) Mookerjee, B. K.; Lee, T. P.; Lippes, H. A.; Middleton, E., Jr.
Some effects of flavonoids on lypmphocyte proliferative re-
sponses. J. Immunopharmacol. 1986, 8, 371-392.
(15) Bracke, M. E.; Bruyneel, E. A.; Vermeulen, S. J.; Vennekens,
K. van Marck, V.; Mareel, M. M. Citrus flavonoid effect on
tumor invasion and metastases. Food Technol. 1994, 48, 121-
124.
(29) Casagrande, F.; Barbon, J. M. Effects of strucurally related
flavonoids on cell cycle progression of human melanoma cells:
regulation of cyclin-dependent kinases CDK2 and CDK1.
Biochem. Pharmacol. 2001, 61, 1205-1215.
(30) Yin, F.; Giuliano, A. E.; Law, R. E.; Van Herle, A. J. Apigenin
inhibits growth and induces GM/M arrest by modulating cyclin-
CDK regulators and ERK MAP kinase activation in breast
carcinoma cells. Anticancer Res. 2001, 2, 413-420.
(31) Wang, W.; Heideman, L.; Chung, C. S.; Pelling, J. C.; Koehler,
K. J.; Birt, D. F. Cell-cycle arrest at G2/M and growth inhibition
by apigenin in human colon carcinoma cell lines. Mol. Carcinog.
2000, 28, 102-110.
(32) Knowles, L. M.; Zigrossi, D. A.; Tauber, R. A.; Hightower, C.;
Milner, J. A. Flavonoids suppress androgen-independent human
prostate tumor proliferation. Nutr. Cancer 2000, 38, 116-122.
(33) Yin, F.; Giuliano, A. E.; Van Herle, A. J. Signal pathways
involved in apigenin inhibition of growth and induction of
apoptosis in human anaplastic thyroid cancer. Anticancer Res.
1999, 19, 4297-4303.
(34) Wang, I. K.; Lin-Shiau, S. Y.; Lin, J. K. Induction of apoptosis
by apigenin and related flavonoids through cytochrome c release
and activation of caspase-9 and caspase-3 in leukaemia HL-60
cells. Eur J. Cancer 1999, 35, 1517-1525.
(35) Caltagirone, S.; Rossi, C.; Poggi, A.; Ranelletti, F. O.; Natalil,
P. G.; Brunetti, M.; Aiello, F. B.; Piantelli, M. Flavonoids
apigenin and quercetin inhibit melanoma growth and metastatic
potential. Int. J. Cancer 2000, 87, 595-600.
(36) Ikegawa, T.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama,
Y.; Naito, M.; Tsuruo, T. Inhibition of P-glycoprotein by orange
juice components, polymethoxyflavones in adriamycin-resistant
human myelogenous leukemia (K562/ADM) cells. Cancer Lett.
2000, 160, 21-28.
(16) Bracke, M. E.; Depypere, H. T.; Boterberg, T.; van Marck, V.
L.; Vennekens, K. M.; Vanluchene, E.; Nuytinck, M.; Serreyn,
R.; Mareel, M. M. Influence of tangeretin on tamoxifen’s
therapeutic benefit in mammary cancer. J. Natl. Cancer Inst.
1999, 91, 354-359.
(37) Rooprai, H. K.; Kandanearatchi, A.; Maidment, S. L. Christidou,
M.; Trillo-Pazos, G.; Dexter, D. T.; Rucklidge, G. J.; Widmer,
W.; Pilkington, G. J. Evaluation of the effects of swainsonine,
captopril, tangeretin, and nobiletin on the biological behaviour
of brain tumor cells in vitro. Neuropathol. Appl. Neurobiol. 2001,
27, 29-39.
(17) Jurd, L. Spectral properties of flavonoid compounds. In The
Chemistry of FlaVonoid Compounds; Geissman, T. A., Ed.;
Pergamon Press: New York, 1962; pp 107-155.
(18) Horowitz, R. M.; Gentili, B. Flavonoids of citrus. IV. Isolation
of some aglycones from the lemon (Citrus limon). J. Org. Chem.
1960, 25, 2183-2187.
(19) Nakashima, R.; Yoshikawa, M.; Matsuura, R. Quercetin 3,7,3′,4′-
tetramethylether from Germanium macrorhizum. Phytochemistry
1973, 12, 1502.
(20) Rao, K. V.; Seshadri, T. R. Nuclear oxidation in the flavone
series. Proc. Ind. Acad. Sci., A 1947, 25, 417-426.
(21) Tatum, J. H.; Berry, R. E. Six new flavonoids from citrus.
Phytochemistry 1972, 11, 2283-2288.
Received for review January 31, 2002. Revised manuscript received
June 14, 2002. Accepted June 18, 2002. Mention of a trademark or
proprietary product is for identification only and does not imply a
guarantee or warranty of the product by the U.S. Department of
Agriculture.
(22) Geissman, T. A.; Steelink, C. Flavonoid petal constituents of
Chrysanthemum segetum L. J. Org. Chem. 1957, 22, 946-948.
JF020121D